Your search for ‘McGuireWoods LLP’ returned 3,630 results

Johnson & Johnson has announced it has accepted a $4 billion binding offer from PE firm Carlyle Group for its Ortho Clinical Diagnostics business.

Metacrine, based in San Diego, Calif., is a biotechnology company focused on advancing research in nuclear hormone receptors for treatment of metabolic diseases originated at the Salk Institute for Biological Studies.

Quest Diagnostics has announced it has entered into a definitive agreement to acquire Solstas Lab Partners Group and its subsidiaries for approximately $570 million.

Surge Private Equity has announced it has invested in Elite Clinical Network (ECN) in a transaction valued at around $200 million.

The legislation passed by a vote of 392-37 with 212 Republicans and 180 Democrats supporting the proposal.

Meridian Surgical Partners, a national operator of outpatient ambulatory surgery centers, announced on September 10 that it had settled a qui tam lawsuit.

Health Diagnostic Laboratory in Virginia and several other labs are under investigation by the Office of Inspector General and Justice Department.

In July 2012, Gov. Patrick signed a partial repeal of the Massachusetts Pharmaceutical and Medical Device Manufacturer Code of Conduct (Code of Conduct).

The fund exceeded its target of $375 million, the firm reported.

We have previously discussed on this blog the ever-increasing federal and state focus on healthcare fraud prevention and enforcement activities.

Brentwood, Tennessee-based RegionalCare Hospital Partners announced another hospital joint venture, this time with Billings Clinic, a community-owned healthcare organization in Billings, Montana.

Overall, AHRQ plans to use the RFI responses to create a summary report for the summer of 2013.

The Centers for Medicare and Medicaid Services (CMS) has delayed the start of required reporting of one-time payments to Medicare beneficiaries by one year.

Revival Healthcare Capital has announced it has closed a new fund with total capital commitments of $500 million.

SK Capital Partners has announced it has closed its latest fund with $800 million in commitments.

U.S. Attorney's Office Settles with Urgent Care Providers to Resolve False Claims Act Allegations Related to Credentialing Issues.

Valeas Capital Partners has announced the closing of its first institutional fund at more than $600 million.

The House Ethics Committee is having a busy holiday season, following up on what was a busy overall year for the congressional ethics panel.